Synthetic Data and Health Privacy
This Viewpoint discusses generative artificial intelligence and safeguarding privacy by using synthetic data as a substitute for private health data.
Related Articles
Best of 2024: Mixed Long-term Effects of Calcium and Vitamin D in Postmenopausal Women | RheumNow
A follow-up analysis of a randomized clinical trial found that the use of calcium and vitamin D supplements among postmenopausal women was associated with decreased…
Seeking Solutions to Burnout Among Emergency Physicians
While the culture is changing slowly, today’s residents and early-career emergency physicians are feeling the stress just as much as previous generations.
Eggs, pizza, Lay’s and more: the mounting list of FDA recalls
The FDA recently gave some Costco eggs their highest recall classification.
Four digital health unicorns on what they expect in 2025
Top executives at Omada, Transcarent, Hinge Health and Maven Clinic reflect on the year that passed, and the year ahead for their companies.
Planet-friendly school meals: opportunities to improve children’s health and leverage change in food systems
Food systems are facing a global crisis. Most countries are falling behind rather than progressing toward achieving the seven global nutrition targets set for 2030,1…
Back to top
Official websites use .gov A.gov website belongs to an official government organization in the United States. Secure .gov websites use HTTPS A lock () or…
How John Deere Robs Farmers Of $4 Billion A Year
John Deere is costing American farmers $4.2 billion a year by restricting them from fixing their own tractors. Apple, Amazon and major automakers use the…
Sex-Based Disparity in CABG Outcomes: Are We Moving Toward Parity?
Historically, women undergoing coronary artery bypass grafting (CABG) and percutaneous coronary intervention (PCI) have had worse outcomes than men
Exercise and Fitness – Special Health Reports – Harvard Health
No reports match the provided keyword. As a service to our readers, Harvard Health Publishing provides access to our library of archived content. Please note…
Aspartate signalling drives lung metastasis via alternative translation
Nature – Aspartate in the tumour environment activates the N-methyl-d-aspartate receptor in cancer cells to induce cellular programmes that increase the aggressiveness of metastasis.
